why choose us

Clinical Trials Search

Showing 7,940 of 132,085 result(s)
Combination of Buffered Anesthetic to Treat Mandibular Molars

Status: Completed

Condition: Symptomatic Irreversible Pulpitis

Interventions: Onpharma's Onset sodium bicarbonate buffer to be added to a standard cartridge of dental local anesthetic

Date: 2023-09-14

Community Health Advocates for Motivating PAP Use in Our Neighborhoods.

Status: NOT_YET_RECRUITING

Condition: Obstructive Sleep Apnea

Interventions: Motivational Enhancement Therapy (MET) is based on the principles of motivational interviewing and is designed to promote self-efficacy and maximize b

Date: 2023-09-14

A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Status: Completed

Condition: Hidradenitis Suppurativa

Interventions: Administered SC

Date: 2023-09-14

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed;Refractory Mantle Cell Lymphoma

Status: Completed

Condition: Lymphoma

Interventions: Participants will receive two 1000 mg pretreatments of intravenous (IV) obinutuzumab from Cycle 1 Day 1

Date: 2023-09-14

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

Status: Completed

Condition: Episodic Migraine

Interventions: Dose "A" U ;Injection (U;I) , Intramuscular (IM) on every 12 weeks during a period of 36 weeks with a total of 4 injections.

Date: 2023-09-14

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

Status: Completed

Condition: Chronic Migraine

Interventions: Dose "A" Unit;Injection (U;I), Intramuscular (IM) on every 12 weeks during a period of 36 weeks with a total of 4 injections.

Date: 2023-09-14

Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment

Status: Completed

Condition: Lung Cancer

Interventions: Delivered by a nurse or other healthcare provider, includes 2 in-person sessions, and phone check-ins, and occurs primarily during infusion visits.

Date: 2023-09-14

A Study of CT-868 in Type 1 Diabetes Mellitus

Status: Completed

Condition: Overweight

Interventions: CT-868 is an investigational medication administered subcutaneously via a pre-filled pen injector device.

Date: 2023-09-14

Daratumumab for Polyneuropathy Associated With MGUS

Status: Completed

Condition: Peripheral Neuropathy

Interventions: subucatneous, fixed dose 1800mg combination drug product containing rHuPH20 drug substance (2000 U;mL) and daratumumab drug substance (120 mg

Date: 2023-09-14

Transcutaneous Auricular Neurostimulation After Lumbar Fusion Surgery

Status: NOT_YET_RECRUITING

Condition: Pain, Postoperative

Interventions: This method of simultaneous vagal and trigeminal stimulation via the external ear is known as transcutaneous auricular neurostimulation (tAN), as the

Date: 2023-09-14